⌘K
Loading ticker…
As of 2026-08-25, Celcuity Inc. Common Stock (CELC) has a 3-month relative strength percentile of 14 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 49. The current market Stance is 52.9 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 5.0%, relative volume 0.75×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
CELC is in a stage 3 topping pattern, week 6. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -1.8% / -12.7%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
CELC is held by 22 ETFs as of May 2026. Top owner: VTWO at 0.14% weight, $24M notional. Top 3 carry $55M.
Held by 55 ETFs · $534M across latest filings · largest weight 3.92% (SBIO).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VTWO | 0.14% | $24M | +0.02 pp |
| SCHASchwab U.S. Small-Cap ETF | 0.10% | $23M | — |
| VHTVanguard Health Care ETF | 0.04% | $8M | +0.02 pp |
| SBIO | 3.92% | $6M | +0.58 pp |
| CANC | 3.58% | $6M | +1.11 pp |
| DWAS | 1.14% | $5M | −0.23 pp |
| VTWG | 0.25% | $4M | +0.03 pp |
| VFMO | 0.18% | $3M | −0.01 pp |
| SCHBSchwab U.S. Broad Market ETF | 0.01% | $3M | — |
| MSSM | 0.23% | $2M | +0.21 pp |
Showing 10 of 22 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
Related searches
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | CELC Jan avg: -6.75% median: -2.54% win: 50% σ: 18.27% n: 4 2022-04-12 → 2026-07-31 | CELC Feb avg: 1.75% median: 2.57% win: 75% σ: 18.01% n: 4 2022-04-12 → 2026-07-31 | CELC Mar avg: 8.80% median: 4.69% win: 75% σ: 21.77% n: 4 2022-04-12 → 2026-07-31 | CELC Apr avg: -4.72% median: 0.19% win: 60% σ: 15.31% n: 5 2022-04-12 → 2026-07-31 | CELC May avg: 2.13% median: 0.31% win: 80% σ: 5.38% n: 5 2022-04-12 → 2026-07-31 | CELC Jun avg: 9.75% median: 3.67% win: 80% σ: 23.34% n: 5 2022-04-12 → 2026-07-31 | CELC Jul avg: 35.52% median: -0.22% win: 40% σ: 88.92% n: 5 2022-04-12 → 2026-07-31 | CELC Aug avg: 4.30% median: -0.34% win: 50% σ: 18.83% n: 4 2022-04-12 → 2026-07-31 (current) | CELC Sep avg: -1.69% median: -3.78% win: 25% σ: 6.19% n: 4 2022-04-12 → 2026-07-31 | CELC Oct avg: 19.07% median: 10.24% win: 75% σ: 25.77% n: 4 2022-04-12 → 2026-07-31 | CELC Nov avg: 10.70% median: 11.24% win: 50% σ: 27.75% n: 4 2022-04-12 → 2026-07-31 | CELC Dec avg: 13.37% median: 0.79% win: 50% σ: 26.66% n: 4 2022-04-12 → 2026-07-31 |